期刊文献+

A771726大鼠在体小肠吸收动力学 被引量:4

The intestinal absorption kinetics of A771726 in rats
下载PDF
导出
摘要 目的探讨A771726大鼠在体各肠段的吸收动力学特征。方法采用大鼠在体小肠回流装置,以UV法和HPLC法分别测定酚红和A771726的含量。结果大鼠十二指肠?空肠?回肠?结肠2h后对A771726的吸收百分率分别为36.0%±2.1%、27.5%±4.2%、38.1%±5.1%、22.5%±2.3%,吸收速率常数分别为0.232±0.023、0.172±0.042、0.261±0.044、0.122±0.011(1/h)。在低、中、高3种不同浓度下,A771726全肠段的吸收速率常数分别为0.712±0.094、0.719±0.106、0.703±0.143(1/h),差异无显著性。结论A771726在大鼠各肠段均有吸收,其吸收机制为被动扩散,吸收动力学为一级吸收。 Objective To investigate the absorption kinetics of A771726 at different intestine segments in rats. Methods The intestine in rats was cannulated in stiu for recirculation. UV and HPLC were used to determine the concentrations of phenol red and A771726, respectively. Results The absorbed rates of A771726 were 36. 0%± 2. 1% ,27.5% ±4. 2% ,38. 1% ±5.1% ,22. 5% ±2. 3% ,and the absorption rate constants (Ka) were 0. 232± 0. 023,0. 172 ± 0. 042,0. 261 ± 0. 044,0. 122 ± 0. 011 ( 1/h) respectively in duodenum, jejunum, ileum and colon. The absorption rate constants of A771726 were 0. 712 ± 0. 094,0. 719 ±0. 106 and 0. 703 ± 0. 143 (1/h), respectively at different concentrations including low, medium, high concentration. Conclusion A771726 is absorbed in all intestine segments of rats with the passive transport mechanism and first order kinetics.
出处 《安徽医科大学学报》 CAS 北大核心 2008年第3期301-304,共4页 Acta Universitatis Medicinalis Anhui
关键词 异嚼 唑类/药代动力学 色谱法 高压液相 分光光 度法 紫外线 肠吸收 isoxazoles/pharmacokinetics chromatography, high pressure liquid spectrophotometry, ultraviolet intestinal absorption
  • 相关文献

参考文献8

二级参考文献60

  • 1胡一桥,郑梁元,钱陈钦,郁伟海.离子型药物酚红的小肠吸收研究[J].中国药科大学学报,1996,27(6):355-359. 被引量:56
  • 2毛凤斐 屠锡德 等.黄芩甙大鼠小肠吸收研究[J].南京药学院学报,1984,15(1):61-69.
  • 3Schorlemmer H U, Milbert U, Zitter D, et al. Cell cycle regulation and inhibition of de novo pyrimidine biosynthesis by leflunomide[J]. Inflamm Res, 1999, 48(Suppl 2) :115 -6.
  • 4Kale Vijay P, Bichile L S. Leflunomide: A novel disease modifying anti-rheumatic drug[J]. J Postgrad Med, 2004, 50(2) : 154 -7.
  • 5Tlacuilo-Parra J A, Guevara-Gutierrez E, Rodriguez-Castellanos M A, et al. Leflunomide in the treatment of psoriasis: results of aphase Ⅱ open trial[J]. Br J Dermatol, 2004, 150(5) : 970 -6.
  • 6Schmitt J, Wozel G. Psoriasis arthritis-long-term treatment of two patients with leflunomide [ J ]. J Dtsch Dermatol Ges, 2004, 2(9) : 763 -6.
  • 7Walsh S R A, Shear N H. Psoriasis and the new biologic agents:interrupting a T-AP dance[J]. CMAJ, 2004, 170(13) : 1933 -41.
  • 8Pfinz J C. The role of T cells in psoriasis[J]. J Eur Acad Dermatol Venereol, 2003, 17 (3) : 257 - 70.
  • 9Cannon G W, Kremer J M. Leflunomide[J]. Rheum Dis Clin North Am, 2004, 30(2) : 295 -309.
  • 10Cutolo M, Seriolo B, Pizzomi C, et al. Methotrexate in psoriatic arthritis[J]. Clin Exp Rheumatol, 2002, 20(6 Suppl 28 ) :76 - 80.

共引文献62

同被引文献36

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部